$HP

HELMERICH HANS sold $4.1M of HP (indirect holdings)

HELMERICH HANS sold 94,470 indirectly-held shares of Helmerich & Payne, Inc. (HP) at $43.90 ($4.15M total) across 3 trades on 2026-08-20.

Original reporting
SEC EDGAR · HELMERICH HANS
Published Aug 24, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HP
Neutral
medium confidence
Mentioned
$HP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HPNeutralLow
01

Why it matters

The disclosed sale provides fresh data for investors but is unlikely to trigger a major price move.

02

Market read

Primary relevance is to HP shareholders; broader market impact is negligible.

03

What to watch

Potential tax planning or portfolio rebalancing rather than lack of confidence.

Relevance 6/10Novelty 7/10Timing: filing date 2026-08-24

Background

Form 4 filings disclose insider transactions; a director's sale is publicly reported and can influence perception.

Company-level read

Ticker impact

$HPNeutralMedium confidence
Context

Director Hans Helmerich sold 94,470 shares for $4.15M, reducing his stake to 20,000 shares.

Expected impact

Potential slight downward pressure on HP stock in the short term.

Evidence & confidence

A $4.1M sale by a director is notable but not large enough to drive a significant move; investors may watch for further insider activity.

Market effects

Minimal impact on the oilfield services sector; insider activity is company‑specific.

No broader regional effect.

Limited to investors tracking HP.

Counterpoint

The sale could be unrelated to fundamentals; price may remain stable.

Key entities

  • Helmerich & Payne, Inc.

    Oilfield services provider listed on NYSE under ticker HP.

  • Hans Helmerich

    Director of Helmerich & Payne who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HPHighAI 8/10

HP Reports Strong Earnings, Stock Drops 10% Amid Demand Concerns

HP Inc. (NYSE: HP) reported Q3 revenue of $15.7B, up 13% YoY, and adjusted EPS of $0.83, beating expectations. Despite this, shares fell 10% due to concerns over demand and declining PC shipments. HP's P/S ratio is higher than its historical median, suggesting overvaluation. Insiders sold $5.24M in shares recently, indicating mixed sentiment.

$HPMedAI 8/10

Helmerich & Payne Q3 Earnings Call Highlights

Helmerich & Payne (NYSE:HP) reported Q3 call highlights. Management said super-spec fleet utilization is ~95%. For fiscal Q4, North America Solutions guidance is 145-151 rigs with direct margin of $245m-$255m, and full-year North American rig count raised to 140-144. International Solutions direct margin was $31m; Offshore was $29m. Company targets net debt/EBITDA of 1x and raised full-year Offshore direct margin to $113m-$117m.

$HPMed

Helmerich & Payne (NYSE:HP) Reports Upbeat Q2 CY2026

Helmerich & Payne (NYSE:HP) reported Q2 CY2026 results. Revenue was $1.03 billion, flat year on year but 5.4% above Wall Street estimates. GAAP profit was $0.74 per share, above analysts’ consensus. The article also cites adjusted EBITDA margin of 22.8% and notes the stock was about $33.59 after results.

$HPMed

Helmerich & Payne, Inc. (HP): Results of Operations and Financial Condition

Helmerich & Payne, Inc. (HP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE August 5, 2026 HELMERICH & PAYNE, INC. ANNOUNCES FISCAL THIRD QUARTER RESULTS Operating and Financial Highlights for the Quarter Ended June 30, 2026 • H&P announced consolidated revenue of $1.035 billion, reflecting strong sequential growth and solid exe

$HPMedAI 8/10

BofA Raises its Price Target on Helmerich & Payne (HP)

On May 19, 2026, BofA analyst Saurabh Pant raised Helmerich & Payne’s (HP) price target to $44 from $41 and kept a Buy rating, citing updated oilfield services models after Q1 earnings and 10-Q filings. BofA said 2027 and 2028 EBITDA forecasts are about 10% and 16% above consensus. Piper Sandler raised its target to $43 from $41 with an Overweight rating.